ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Arthroplasty"

  • Abstract Number: 2521 • ACR Convergence 2023

    Understanding Age as a Risk Factor for Complications After Total Knee Arthroplasty: What Can We Learn from Machine Learning?

    Bella Mehta1, Yi Yiyuan2, Chloe Heiting3, Kaylee Ho2, Susan Goodman3, Peter Sculco3, Fei Wang2, Rich Caruana4, Peter cram5 and Said Ibrahim6, 1Hospital for Special Surgery, Weill Cornell Medicine, New York, NY, 2Weill Cornell Medicine, New York, NY, 3Hospital for Special Surgery, New York, NY, 4Microsoft, Redmond, WA, 5The University of Texas Medical Branch, Galveston, TX, 6Northwell Health, New Hyde Park, NY

    Background/Purpose: Rates of total knee arthroplasty (TKA) in the United Stateshave risen, coupled with increasing demand for TKAs in younger patients.1Althoughrates of postoperative complications in…
  • Abstract Number: 0165 • ACR Convergence 2023

    Hypothyroidism Is Associated with Worse Clinical and Utilization Outcomes After Primary Total Knee Arthroplasty

    Sumanth Chandrupatla1, Kranti Rumalla2 and Jasvinder Singh1, 1University of Alabama at Birmingham, Birmingham, AL, 2Northwestern School of Medicine, Chicago, IL

    Background/Purpose: Limited information is available regarding how medical comorbidities affect the outcomes of total knee arthroplasty (TKA). The association of medical comorbidities with post-TKA outcomes…
  • Abstract Number: 2522 • ACR Convergence 2023

    Diabetes Mellitus Impacts Primary Total Hip Arthroplasty Outcomes: A National Cohort Study

    Sumanth Chandrupatla1, Kranti Rumalla2 and Jasvinder Singh1, 1University of Alabama at Birmingham, Birmingham, AL, 2Northwestern School of Medicine, Chicago, IL

    Background/Purpose: Primary total hip arthroplasty (THA) patients often have concomitant medical comorbidities. This study aims to identify the impact of diabetes mellitus (DM) on inpatient…
  • Abstract Number: 0313 • ACR Convergence 2023

    The Influence of Pain Catastrophizing on Pain and Function After Knee Arthroplasty for Osteoarthritis

    Diana, Xin Hui Chan1, Seyed Ehsan Saffari2, Steven, Bak Siew Wong3, Seng Jin Yeo1, Vikki Wylde4, Julian Thumboo1 and Ying Ying Leung1, 1Singapore General Hospital, Singapore, Singapore, 2Center for Quantitative Medicine, Duke-NUS Medical School, National University of Singapore, Singapore, Singapore, 3Sengkang General Hospital, Singapore, Singapore, 4University of Bristol, Bristol, United Kingdom

    Background/Purpose: To evaluate the association between pre-operative pain catastrophizing and pain and function outcomes up to one year after knee arthroplasty. Methods: We used data…
  • Abstract Number: 2523 • ACR Convergence 2023

    Region, Race, and Hospital Factors Impact Length of Stay and Hospital Charges Post-primary Total Knee Arthroplasty

    Kranti Rumalla1, Sumanth Chandrupatla2 and Jasvinder Singh2, 1Northwestern School of Medicine, Chicago, IL, 2University of Alabama at Birmingham, Birmingham, AL

    Background/Purpose: Osteoarthritis (OA) affects nearly 33 million adults in the US and total knee arthroplasty (TKA) is an effective treatment. Outcomes can vary by regional…
  • Abstract Number: 0321 • ACR Convergence 2023

    Use of Proton Pump Inhibitors and Risk of Hip/knee Joint Replacement Among Patients with Osteoarthritis and Rheumatoid Arthritis

    Koushik Sangaraju1, Radu Grovu2, Michael Kwark2, Elizabeth Cohen2, Amira Hassan3 and Anastasia Slobodnick2, 1Staten Island University Hospital - Northwell Health, Staten Island, NY, 2Northwell Health, Staten Island, NY, 3Northwell Health, Brooklyn, NY

    Background/Purpose: Osteoarthritis and rheumatoid arthritis cause significant joint replacement morbidity. Proton pump inhibitors (PPIs) may contribute to chronic inflammation and joint degeneration due to side…
  • Abstract Number: 2534 • ACR Convergence 2023

    A Novel Approach for Mixed-methods Research Using Language Learning Models: A Report Using Patients’ Perspectives on Barriers to Hip and Knee Replacement

    Insa Mannstadt1, Susan Goodman1, Mangala Rajan2, Sarah Young3, Fei Wang2, Iris Navarro-Millán4 and Bella Mehta5, 1Hospital for Special Surgery, New York, NY, 2Weill Cornell Medicine, New York, NY, 3Binghamton University, Binghamton, NY, 4Weill Cornell Medicine, Hospital for Special Surgery, New York, NY, 5Hospital for Special Surgery, Weill Cornell Medicine, New York, NY

    Background/Purpose: While qualitative research techniques provide valuable insights into patient experiences and perceptions, analyzing textual data from interviews can be time consuming and require multiple…
  • Abstract Number: 0991 • ACR Convergence 2023

    Trends in Arthroplasty Utilization for Inflammatory Arthritis Including Rheumatoid Arthritis and Spondyloarthritis in China: Analysis of a Large National Database

    Dongxing Xie1, Qiao Jiang2, Yuqing Wang2, Huizhong Long2, Hu Chen3, Jie Wei4, Xiaoxiao Li5, Haibo Wang6, Chao Zeng7 and Guanghua Lei7, 1Xiangya Hospital, Central South University, Changsha, China, 2Xiangya Hospital, Changsha, China, 3Tibet Autonomous Region People’s Hospital, Lhasa, China, 4Health Management Center, Xiangya Hospital Central South University, Changsha, China, 5Key Laboratory of Aging-related Bone and Joint Diseases Prevention and Treatment, Ministry of Education, Xiangya Hospital, Central South University, Changsha, China, 6China Standard Medical Information Research Center, Shenzhen, China, 7Department of Orthopaedics, Xiangya Hospital, Central South University, Changsha, China

    Background/Purpose: For end-stage inflammatory arthritis (IA) including rheumatoid arthritis (RA) and spondyloarthritis (SpA), joint arthroplasty is the only treatment option, but is considered to be…
  • Abstract Number: 2592 • ACR Convergence 2023

    Trends, Sociodemographic and Clinical Factors Associated with Avascular Necrosis and Related Arthroplasties in Hospitalized Patients with Systemic Lupus Erythematosus and Rheumatoid Arthritis

    Rashmi Dhital1, Neha Singh2, Brian Pedersen2 and Christie M. Bartels3, 1UC San Diego, San Diego, CA, 2University of California San Diego, San Diego, CA, 3University of Wisconsin, School of Medicine and Public Health, Madison, WI

    Background/Purpose: Avascular necrosis (AVN) can be a debilitating complication of autoimmune diseases and steroid treatment, with a higher prevalence in systemic lupus erythematosus (SLE) (0.8-33%)…
  • Abstract Number: 0999 • ACR Convergence 2023

    Race, Payer, and Hospital Factors Are Associated with Post-primary Total Hip Arthroplasty Healthcare Utilization

    Kranti Rumalla1, Sumanth Chandrupatla2 and Jasvinder Singh2, 1Northwestern School of Medicine, Chicago, IL, 2University of Alabama at Birmingham, Birmingham, AL

    Background/Purpose: Over 450,000 primary total hip arthroplasties (THA) are performed each year. One major indication for primary THA is the presence of osteoarthritis (OA). Patient…
  • Abstract Number: 1021 • ACR Convergence 2023

    Racial Disparities Between Black and White Patients in Joint Replacement Surgery: A Systematic Review

    Max Krall1, Samuel Good1, Collin Brantner2, Diyu Pearce-Fisher2, Susan Goodman2, Michael Parks2, Peter Sculco2, Cynthia Kahlenberg2, Ajay Premkumar2, Michelle Demetres3 and John FitzGerald1, 1University of California Los Angeles, Los Angeles, CA, 2Hospital for Special Surgery, New York, NY, 3Weill Cornell Medicine, New York, NY

    Background/Purpose: Despite the documented efficacy of joint replacement surgery (JRS) for the management of refractory hip or knee osteoarthritis (OA), multiple studies have documented lower…
  • Abstract Number: 1026 • ACR Convergence 2023

    Patients’ Barriers to Total Joint Arthroplasty: Associations with the Orthopedic Consultation

    Insa Mannstadt1, J. Alex Gibbons2, Troy Amen1, Mangala Rajan3, Sarah Young4, Michael Parks1, Mark Figgie1, Anne Bass5, Linda Russell1, Bella Mehta5, iris Navarro-Millán1 and Susan Goodman1, 1Hospital for Special Surgery, New York, NY, 2Columbia University Vagelos College of Physicians & Surgeons, New York, NY, 3Weill Cornell Medicine, New York, NY, 4Binghamton University, Binghamton, NY, 5Hospital for Special Surgery, Weill Cornell Medicine, New York, NY

    Background/Purpose: While racial/ethnic disparities in total joint arthroplasty (TJA) utilization are well-documented, the impact of orthopedic specialists on patients' perceptions of TJA is poorly understood.…
  • Abstract Number: 1027 • ACR Convergence 2023

    Single-Payer Health Insurance May Not Mitigate Income-Based Differences in Total Hip Arthroplasty Utilization: A Transnational Analysis

    Bella Mehta1, Kaylee Ho2, J. Alex Gibbons3, Vicki Ling4, Susan Goodman5, Michael Parks5, Bheeshma Ravi6, Fei Wang2, Said Ibrahim7 and Peter cram8, 1Hospital for Special Surgery, Weill Cornell Medicine, New York, NY, 2Weill Cornell Medicine, New York, NY, 3Columbia University Vagelos College of Physicians & Surgeons, New York, NY, 4Institute for Clinical Evaluative Sciences, Toronto, ON, Canada, 5Hospital for Special Surgery, New York, NY, 6Sunnybrook Health Sciences Centre, Toronto, ON, Canada, 7Northwell Health, New York, NY, 8The University of Texas Medical Branch, Galveston, TX

    Background/Purpose: Access to care varies across health systems. Countries with universal health insurance are thought to have less wealth-based health disparities, but it is unclear…
  • Abstract Number: 1028 • ACR Convergence 2023

    Barriers to Total Joint Arthroplasty for Patients Residing in High-Poverty Communities

    J. Alex Gibbons1, Insa Mannstadt2, Troy Amen2, Mangala Rajan3, Sarah Young4, Michael Parks2, Mark Figgie2, Anne Bass5, Linda Russell2, Bella Mehta5, Iris Navarro-Millán6 and Susan Goodman2, 1Columbia University Vagelos College of Physicians & Surgeons, New York, NY, 2Hospital for Special Surgery, New York, NY, 3Weill Cornell Medicine, New York, NY, 4Binghamton University, Binghamton, NY, 5Hospital for Special Surgery, Weill Cornell Medicine, New York, NY, 6Weill Cornell Medicine, Hospital for Special Surgery, New York, NY

    Background/Purpose: Patients from lower socioeconomic status (SES) backgrounds have low access to total joint arthroplasty (TJA), delays in undergoing TJA, and a higher risk of…
  • Abstract Number: 1189 • ACR Convergence 2023

    Evaluating Neuropathic and Nociplastic Pain in Patients with Hip and Knee Osteoarthritis

    Carly Conran1, Larry Moreland2, Andrew Clauw1, Jennifer Seifert1, Carson Keeter3, Craig Hogan1 and Michael Dayton1, 1University of Colorado Anschutz Medical Campus, Aurora, CO, 2University of Colorado, Denver, CO, 3University of Colorado, Aurora, CO

    Background/Purpose: Chronic pain in patients with hip and knee osteoarthritis (OA) has been classically attributed to nociceptive pain pathways. Emerging evidence has demonstrated influence from…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • …
  • 7
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology